Showing results (11-20 of 298) with videos related to

Sort By:
Pageof 30
Current Pharmaceutical Design|February 12, 2013
From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insightsSamuele De Minicis, Chris Day, Gianluca Svegliati-Baroni
Gastroenterology|June 25, 2009
c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in miceYuzo Kodama, Tatiana Kisseleva, Keiko Iwaisako, et al.
Annals of Translational Medicine|October 22, 2014
New insights in hepatocellular carcinoma: from bench to bedsideSamuele De Minicis, Marco Marzioni, Antonio Benedetti, et al.
The Journal of Clinical Investigation|July 16, 2009
CCR1 and CCR5 promote hepatic fibrosis in miceEkihiro Seki, Samuele De Minicis, Geum-Youn Gwak, et al.
Fibrogenesis & Tissue Repair|December 25, 2012
Origin of myofibroblasts in liver fibrosisDavid A Brenner, Tatiana Kisseleva, David Scholten, et al.
Gastroenterology|October 1, 2008
Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosisKojiro Taura, Samuele De Minicis, Ekihiro Seki, et al.
Hepatology (Baltimore, Md.)|August 7, 2010
Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosisSamuele De Minicis, Ekihiro Seki, Yong-Han Paik, et al.
Hepatology (Baltimore, Md.)|August 4, 2009
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in miceChristoph H Osterreicher, Kojiro Taura, Samuele De Minicis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 9, 2010
From the metabolic syndrome to NAFLD or vice versa?Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, et al.
The American Journal of Pathology|July 16, 2013
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesisSamuele De Minicis, Chiara Rychlicki, Laura Agostinelli, et al.
Pageof 30